Physician profile
Richard C Schultz
NPI 1386612935
$3,560.92
in general payments reported to CMS, 2019-2025
17 companies · $254 in 2025
The $254 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $326 · 2020: $180 · 2021: $1,454 · 2022: $448 · 2023: $372 · 2024: $527 · 2025: $254.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,126 · Education: $27.52.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,125.53 |
| Education | $27.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,634.41 | 2021-2025 | Inspire |
| Aerin Medical INC. | $961.09 | 2019-2025 | |
| Intersect Ent, INC. | $229.07 | 2019-2020 | |
| Glaxosmithkline, LLC. | $217.85 | 2022-2025 | Nucala |
| Acclarent, INC | $121.38 | 2019-2022 | |
| Stryker Corporation | $80.75 | 2019 | |
| Medtronic, INC. | $70.61 | 2022-2025 | Propel |
| Karl Storz Endoscopy-America | $35.50 | 2022-2023 | N.A. |
| Olympus America INC. | $32.97 | 2019-2022 | |
| Genzyme Corporation | $30.61 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $27.52 | 2024 | Eohilia |
| Ethicon US, LLC | $24.62 | 2024 | Surgicel Nu-Knit |
| Alk-Abello, INC | $21.94 | 2020 | |
| Integra Lifesciences Corporation | $21.75 | 2024 | Trudi Probe, Relieva Spinplus Nav, Inspira Air |
| Paratek Pharmaceuticals, INC. | $20.09 | 2025 | Xhance |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $17.48 | 2025 | Tezspire |
| Smith+Nephew, INC. | $13.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Schultz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.